• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧的治疗性调节

Therapeutic Modification of Hypoxia.

作者信息

Horsman M R, Sørensen B S, Busk M, Siemann D W

机构信息

Experimental Clinical Oncology - Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.

Experimental Clinical Oncology - Department of Oncology, Aarhus University Hospital, Aarhus, Denmark; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.

出版信息

Clin Oncol (R Coll Radiol). 2021 Nov;33(11):e492-e509. doi: 10.1016/j.clon.2021.08.014. Epub 2021 Sep 14.

DOI:10.1016/j.clon.2021.08.014
PMID:34535359
Abstract

Regions of reduced oxygenation (hypoxia) are a characteristic feature of virtually all animal and human solid tumours. Numerous preclinical studies, both in vitro and in vivo, have shown that decreasing oxygen concentration induces resistance to radiation. Importantly, hypoxia in human tumours is a negative indicator of radiotherapy outcome. Hypoxia also contributes to resistance to other cancer therapeutics, including immunotherapy, and increases malignant progression as well as cancer cell dissemination. Consequently, substantial effort has been made to detect hypoxia in human tumours and identify realistic approaches to overcome hypoxia and improve cancer therapy outcomes. Hypoxia-targeting strategies include improving oxygen availability, sensitising hypoxic cells to radiation, preferentially killing these cells, locating the hypoxic regions in tumours and increasing the radiation dose to those areas, or applying high energy transfer radiation, which is less affected by hypoxia. Despite numerous clinical studies with each of these hypoxia-modifying approaches, many of which improved both local tumour control and overall survival, hypoxic modification has not been established in routine clinical practice. Here we review the background and significance of hypoxia, how it can be imaged clinically and focus on the various hypoxia-modifying techniques that have undergone, or are currently in, clinical evaluation.

摘要

氧合降低区域(缺氧)实际上是所有动物和人类实体瘤的一个特征。大量的临床前体外和体内研究表明,降低氧浓度会诱导对辐射的抗性。重要的是,人类肿瘤中的缺氧是放疗结果的一个负面指标。缺氧还会导致对包括免疫疗法在内的其他癌症治疗方法产生抗性,并增加恶性进展以及癌细胞扩散。因此,人们付出了巨大努力来检测人类肿瘤中的缺氧情况,并确定克服缺氧和改善癌症治疗结果的切实可行方法。针对缺氧的策略包括提高氧的可利用性、使缺氧细胞对辐射敏感、优先杀死这些细胞、定位肿瘤中的缺氧区域并增加对这些区域的辐射剂量,或应用受缺氧影响较小的高能量转移辐射。尽管对这些缺氧改善方法中的每一种都进行了大量临床研究,其中许多方法都改善了局部肿瘤控制和总生存期,但缺氧改善尚未在常规临床实践中确立。在此,我们综述缺氧的背景和意义、其临床成像方法,并重点关注已进行或目前正在进行临床评估的各种缺氧改善技术。

相似文献

1
Therapeutic Modification of Hypoxia.缺氧的治疗性调节
Clin Oncol (R Coll Radiol). 2021 Nov;33(11):e492-e509. doi: 10.1016/j.clon.2021.08.014. Epub 2021 Sep 14.
2
The impact of hypoxia and its modification of the outcome of radiotherapy.缺氧的影响及其对放射治疗结果的改变。
J Radiat Res. 2016 Aug;57 Suppl 1(Suppl 1):i90-i98. doi: 10.1093/jrr/rrw007. Epub 2016 Mar 16.
3
The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments.缺氧肿瘤微环境、患者选择及缺氧修饰治疗
Clin Oncol (R Coll Radiol). 2007 Aug;19(6):385-96. doi: 10.1016/j.clon.2007.03.001. Epub 2007 Apr 12.
4
Hypoxia dose painting in SBRT - the virtual clinical trial approach.SBRT 中的缺氧剂量描绘——虚拟临床试验方法。
Acta Oncol. 2023 Oct;62(10):1239-1245. doi: 10.1080/0284186X.2023.2258272. Epub 2023 Sep 15.
5
LET-painting increases tumour control probability in hypoxic tumours.LET 染色提高乏氧肿瘤的肿瘤控制概率。
Acta Oncol. 2014 Jan;53(1):25-32. doi: 10.3109/0284186X.2013.832835. Epub 2013 Sep 10.
6
Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment.克服肿瘤乏氧作为癌症治疗中放疗、化疗和免疫治疗的障碍。
Int J Nanomedicine. 2018 Oct 4;13:6049-6058. doi: 10.2147/IJN.S140462. eCollection 2018.
7
Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study.通过辐射剂量重新分布优化缺氧肿瘤的肿瘤控制概率:一项建模研究。
Phys Med Biol. 2007 Jan 21;52(2):499-513. doi: 10.1088/0031-9155/52/2/013. Epub 2006 Dec 29.
8
Imaging hypoxia to improve radiotherapy outcome.利用影像学技术检测肿瘤乏氧,改善放射治疗效果。
Nat Rev Clin Oncol. 2012 Dec;9(12):674-87. doi: 10.1038/nrclinonc.2012.171. Epub 2012 Nov 13.
9
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response.定义肿瘤中的常氧、氧合和缺氧——对治疗反应的影响。
Br J Radiol. 2014 Mar;87(1035):20130676. doi: 10.1259/bjr.20130676.
10
The meaning, measurement and modification of hypoxia in the laboratory and the clinic.实验室及临床环境下低氧的含义、测量与改善
Clin Oncol (R Coll Radiol). 2014 May;26(5):277-88. doi: 10.1016/j.clon.2014.02.002. Epub 2014 Mar 3.

引用本文的文献

1
Current Research Trends and Hotspots in Radiotherapy Combined with Nanomaterials for Cancer Treatment: A Bibliometric and Visualization Analysis.放疗联合纳米材料治疗癌症的当前研究趋势与热点:文献计量学与可视化分析
Nanomaterials (Basel). 2025 Aug 6;15(15):1205. doi: 10.3390/nano15151205.
2
Recent Progress of Nanomedicine for the Synergetic Treatment of Radiotherapy (RT) and Photothermal Treatment (PTT).用于放疗(RT)与光热疗法(PTT)协同治疗的纳米医学最新进展
Cancers (Basel). 2025 Jul 10;17(14):2295. doi: 10.3390/cancers17142295.
3
Development and validation of cost-effective multi-sample hypoxia chambers for proton ultra-high dose rate organoid irradiations.
用于质子超高剂量率类器官辐照的经济高效多样本缺氧室的开发与验证
Clin Transl Radiat Oncol. 2025 May 1;53:100970. doi: 10.1016/j.ctro.2025.100970. eCollection 2025 Jul.
4
Targeting metastasis in paediatric bone sarcomas.靶向治疗小儿骨肉瘤的转移
Mol Cancer. 2025 May 29;24(1):153. doi: 10.1186/s12943-025-02365-z.
5
Hypoxia signaling in cancer: HIF-1α stimulated by COVID-19 can lead to cancer progression and chemo-resistance in oral squamous cell carcinoma (OSCC).癌症中的缺氧信号传导:由新冠病毒(COVID-19)刺激的缺氧诱导因子-1α(HIF-1α)可导致口腔鳞状细胞癌(OSCC)的癌症进展和化疗耐药性。
Discov Oncol. 2025 Mar 26;16(1):399. doi: 10.1007/s12672-025-02150-w.
6
The immunometabolic topography of tuberculosis granulomas governs cellular organization and bacterial control.结核肉芽肿的免疫代谢格局决定细胞组织和细菌控制。
bioRxiv. 2025 Feb 23:2025.02.18.638923. doi: 10.1101/2025.02.18.638923.
7
Exploring the Metabolic Impact of FLASH Radiotherapy.探索FLASH放疗的代谢影响。
Cancers (Basel). 2025 Jan 3;17(1):133. doi: 10.3390/cancers17010133.
8
Hypoxia studies in non‑small cell lung cancer: Pathogenesis and clinical implications (Review).非小细胞肺癌中的缺氧研究:发病机制与临床意义(综述)
Oncol Rep. 2025 Feb;53(2). doi: 10.3892/or.2024.8862. Epub 2025 Jan 3.
9
Mitochondria-targeted antioxidant MitoQ radiosensitizes tumors by decreasing mitochondrial oxygen consumption.线粒体靶向抗氧化剂MitoQ通过降低线粒体氧消耗使肿瘤对放疗增敏。
Cell Death Discov. 2024 Dec 27;10(1):514. doi: 10.1038/s41420-024-02277-9.
10
Impact of cell geometry, cellular uptake region, and tumour morphology on Ac and Lu dose distributions in prostate cancer.细胞几何形状、细胞摄取区域和肿瘤形态对前列腺癌中锕(Ac)和镥(Lu)剂量分布的影响。
EJNMMI Phys. 2024 Nov 21;11(1):97. doi: 10.1186/s40658-024-00700-9.